SCHEMBL22947480

SCHEMBL22947480

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4-c4ccc5c(c4)S(c4ccccc4)(c4ccccc4)c4ccccc4-5)n3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.36
KMT2A Q03164 6/20 0.36
MAPT P10636 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.36
ADORA2A P29274 3/20 0.36
ADORA1 P30542 3/20 0.36
ADORA3 P0DMS8 2/20 0.36
ADORA2B P29275 2/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
LMNA P02545 3/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ATM Q13315 2/20 0.34
APAF1 O14727 1/20 0.34
THRB P10828 1/20 0.34
XBP1 P17861 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22949598 0.99 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947695 0.93 MEN1 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947522 0.93 MEN1 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947646 0.93 MEN1 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947556 0.91 MEN1 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947517 0.91 NPC1 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22949682 0.90 NPC1 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947666 0.89 MAPT (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22949665 0.89 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22949297 0.86 L3MBTL1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 MEN1 2439/4885KMT2A 2115/4885MAPT 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.